Screener
Biogen BIIB Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Biogen’s reported figures.
Based on trailing twelve months.
The source filing: Biogen’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
FAQ
- What is Biogen's return on equity?
- Biogen (BIIB) reported return on equity of 4.8% in Q2 2026.
- How has Biogen's return on equity changed year-over-year?
- Biogen's return on equity decreased by 47.0% year-over-year, from 9.1% to 4.8%.
- What is the long-term trend for Biogen's return on equity?
- Over 5 years (2020 to 2025), Biogen's return on equity has grown at a -25.4% compound annual growth rate (CAGR), from 33.3% to 7.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Biogen's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude